VASTEN Side Effects

5694452-7 | Alveolitis, Bronchitis, Interstitial Lung Disease, Renal Impairment
on Mar 27, 2008 Male patient from FRANCE , 64 years of age, was diagnosed with dyslipidaemia, renal transplant, benign prostatic hyperplasia, gout (What is gout?), hypertension, gastrooesophageal reflux disease and was treated with Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: alveolitis, bronchitis (What is bronchitis?), interstitial lung disease, renal impairment. Vasten dosage: Tablets.. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), XATRAL (Controlled/modified Release Tablets.) (View Xatral Review and Xatral Label ), MYFORTIC (Gastro-resistant Sugar-coated Tablets.) (View Myfortic Review and Myfortic Label ), ALLOPURINOL (Tablets.) (View Allopurinol Review and Allopurinol Label ), PROGRAF (Capsules.) (View Prograf Review and Prograf Label ), ISOPTIN (Tablets.) (View Isoptin Review and Isoptin Label ), NEXIUM (Gastro-resistant Tablets.) (View Nexium Review and Nexium Label ), KARDEGIC (Oral Suspension.) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

5689233-4 | Tendonitis
Patient was taking Vasten (View Usage). Patient had the following side effects: tendonitis on Mar 26, 2008 from FRANCE Additional patient health information: Male patient , 65 years of age, was diagnosed with dyslipidaemia, bronchitis chronic, hypertension and. Vasten dosage: . During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), TAVANIC (View Tavanic Review and Tavanic Label ), SPIRIVA (Aerosol(suspension)) (View Spiriva Review and Spiriva Label ), BRONCHODUAL (Aerosol(suspension)) (View Bronchodual Review and Bronchodual Label ), AMLOR (Tablets) (View Amlor Review and Amlor Label ), COZAAR (Tablets) (View Cozaar Review and Cozaar Label ), HYZAAR (Tablets) (View Hyzaar Review and Hyzaar Label ), LASILIX (Tablets) (View Lasilix Review and Lasilix Label ). Patient was hospitalized.

5301658-5 |
Adverse event was reported on Apr 11, 2007 by a Female patient taking Vasten (View Usage) (Dosage: ) . Location: FRANCE , 64 years of age, .

5288042-8 | Corneal Disorder, Corneal Epithelium Defect, Dry Eye, Visual Acuity Reduced, Visual Disturbance
on Mar 28, 2007 Female patient from FRANCE , 82 years of age, was diagnosed with hypercholesterolaemia, hypothyroidism, hypertension, cardiac disorder, gastrointestinal disorder, osteoarthritis (What is osteoarthritis?), sleep disorder (What is sleep disorder?) and was treated with Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: corneal disorder, corneal epithelium defect, dry eye, visual acuity reduced, visual disturbance. Vasten dosage: Initial Dosage Was 10mg From 1991-13-oct-2004. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), VASTAREL (View Vastarel Review and Vastarel Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), DEBRIDAT (View Debridat Review and Debridat Label ), CHONDROITIN SULFATE (View Chondroitin Sulfate Review and Chondroitin Sulfate Label ), TEMESTA (View Temesta Review and Temesta Label ).


5255062-9 | Hypoglycaemia
on Feb 21, 2007 Male patient from FRANCE , 67 years of age, was treated with Vasten (View Usage). Patient had the following side effects: hypoglycaemia. Vasten dosage: . During the same period patient was treated with NOVONORM (View Novonorm Review and Novonorm Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), NEXIUM (View Nexium Review and Nexium Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), PLAVIX (View Plavix Review and Plavix Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5246489-X | Pulmonary Embolism
Patient was taking Vasten (View Usage). After Vasten was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Feb 21, 2007 from FRANCE Additional patient health information: Male patient , 49 years of age, was diagnosed with hypercholesterolaemia, psoriasis, embolism, myocardial infarction and. Vasten dosage: . During the same period patient was treated with RAPTIVA (View Raptiva Review and Raptiva Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

5234547-5 | Pulmonary Embolism
Adverse event was reported on Jan 25, 2007 by a Male patient taking Vasten (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, psoriasis, embolism, myocardial infarction and. Location: FRANCE , 49 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with RAPAMUNE (View Rapamune Review and Rapamune Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLOR (View Amlor Review and Amlor Label ).

5232645-3 | Pancytopenia
on Jan 19, 2007 Female patient from FRANCE , 74 years of age, was diagnosed with hypercholesterolaemia and was treated with Vasten (View Usage). Patient had the following side effects: pancytopenia. Vasten dosage: . During the same period patient was treated with ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ). Patient was hospitalized.

5160199-9 | Rectal Haemorrhage
on Nov 06, 2006 Female patient from FRANCE , 91 years of age, was treated with Vasten (View Usage). After Vasten was administered, patient had the following side effects: rectal haemorrhage. Vasten dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CORDARONE (View Cordarone Review and Cordarone Label ), PREVISCAN (View Previscan Review and Previscan Label ), IMODIUM (View Imodium Review and Imodium Label ), TIORFAN (View Tiorfan Review and Tiorfan Label ), LASIX (View Lasix Review and Lasix Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

5148845-7 | Rectal Haemorrhage
Patient was taking Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: rectal haemorrhage on Nov 06, 2006 from FRANCE Additional patient health information: Female patient , 91 years of age, . Vasten dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CORDARONE (View Cordarone Review and Cordarone Label ), PREVISCAN (View Previscan Review and Previscan Label ), IMODIUM (View Imodium Review and Imodium Label ), TIORFAN (View Tiorfan Review and Tiorfan Label ), LASIX (View Lasix Review and Lasix Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

5144213-2 | Blood Creatinine Increased
Adverse event was reported on Oct 30, 2006 by a Male patient taking Vasten (View Usage) (Dosage: ) was diagnosed with myocardial infarction, bronchial carcinoma, deep vein thrombosis (What is deep vein thrombosis?) and. Location: FRANCE , 73 years of age, Patient had the following side effects: blood creatinine increased. During the same period patient was treated with CORVASAL (View Corvasal Review and Corvasal Label ), TRIATEC (View Triatec Review and Triatec Label ), TILDIEM (View Tildiem Review and Tildiem Label ), ALIMTA (View Alimta Review and Alimta Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5131485-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Muscular Weakness, Myalgia, Transaminases Increased
on Sep 22, 2006 Male patient from FRANCE , weighting 173.5 lb, was diagnosed with hypercholesterolaemia, angina pectoris, stent placement and was treated with Vasten (View Usage). After Vasten was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, muscular weakness, myalgia, transaminases increased. Vasten dosage: . During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

5130346-3 | Blood Creatine Phosphokinase Increased, Fatigue, Muscular Weakness, Myalgia, Transaminases Increased
on Sep 22, 2006 Male patient from FRANCE , 49 years of age, weighting 174.2 lb, was diagnosed with hypercholesterolaemia, angina pectoris and was treated with Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, fatigue, muscular weakness, myalgia, transaminases increased. Vasten dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TENORMIN (View Tenormin Review and Tenormin Label ).

5124249-8 | Insomnia, Myalgia, Pain In Extremity, Tendonitis
Patient was taking Vasten (View Usage). Patient had the following side effects: insomnia, myalgia, pain in extremity, tendonitis on Sep 04, 2006 from FRANCE Additional patient health information: Male patient , 71 years of age, was diagnosed with hypercholesterolaemia, coronary artery bypass (What is coronary artery bypass?), myocardial infarction and. Vasten dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SECTRAL (View Sectral Review and Sectral Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), TANAKAN (View Tanakan Review and Tanakan Label ), VOLTAREN (View Voltaren Review and Voltaren Label ).

5121512-1 | Blood Creatine Phosphokinase Increased, Muscular Weakness, Myalgia, Transaminases Increased
Adverse event was reported on Sep 22, 2006 by a Male patient taking Vasten (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, stent placement and. Location: FRANCE , 40 years of age, After Vasten was administered, patient had the following side effects: blood creatine phosphokinase increased, muscular weakness, myalgia, transaminases increased. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

5120498-3 | Blood Creatine Phosphokinase Increased, Muscular Weakness, Myalgia, Transaminases Increased
on Sep 22, 2006 Male patient from FRANCE , 40 years of age, was diagnosed with hypercholesterolaemia, stent placement and was treated with Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, muscular weakness, myalgia, transaminases increased. Vasten dosage: Unk. During the same period patient was treated with PLAVIX (Unk) (View Plavix Review and Plavix Label ).

5102814-1 | Myalgia, Tendonitis
on Sep 04, 2006 Male patient from FRANCE , 71 years of age, was diagnosed with hypercholesterolaemia and was treated with Vasten (View Usage). Patient had the following side effects: myalgia, tendonitis. Vasten dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SECTRAL (View Sectral Review and Sectral Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ).

5069601-4 | Subdural Haematoma
Patient was taking Vasten (View Usage). After Vasten was administered, patient had the following side effects: subdural haematoma on Jul 25, 2006 from FRANCE Additional patient health information: Female patient , 78 years of age, was diagnosed with hypercholesterolaemia, atrial fibrillation (What is atrial fibrillation?) and. Vasten dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5063525-4 | Diabetes Mellitus
Adverse event was reported on Jul 17, 2006 by a Female patient taking Vasten (View Usage) (Dosage: ) was diagnosed with lipids abnormal and. Location: FRANCE , 16 years of age, Patient experienced the following unwanted or unexpected effects: diabetes mellitus. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SOLUPRED (View Solupred Review and Solupred Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), NEORAL (View Neoral Review and Neoral Label ). Patient was hospitalized.

4959586-0 | Abortion Induced, Cleft Lip And Palate, Clinodactyly, Congenital Cerebellar Agenesis, Hydrocephalus, Pregnancy
on May 31, 2005 Female patient from FRANCE , 32 years of age, was diagnosed with hypercholesterolaemia and was treated with Vasten (View Usage). Patient had the following side effects: abortion induced, cleft lip and palate (What is cleft lip and palate?), clinodactyly, congenital cerebellar agenesis, hydrocephalus (What is hydrocephalus?), pregnancy (What is pregnancy?). Vasten dosage: . During the same period patient was treated with DAFLON (View Daflon Review and Daflon Label ).

4897493-2 | Osteoarthritis
on Dec 05, 2005 Female patient from FRANCE , 91 years of age, was treated with Vasten (View Usage). After Vasten was administered, patient had the following side effects: osteoarthritis (What is osteoarthritis?). Vasten dosage: .

4896670-4 | Arterial Stenosis, Carotid Artery Atheroma, Coronary Artery Occlusion, Low Density Lipoprotein Increased, Myocardial Infarction
Patient was taking Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: arterial stenosis, carotid artery atheroma, coronary artery occlusion, low density lipoprotein increased, myocardial infarction on Jan 19, 2006 from FRANCE Additional patient health information: Male patient , 55 years of age, was diagnosed with lipid metabolism disorder, back pain (What is back pain?), anxiety (What is anxiety?), osteoarthritis (What is osteoarthritis?), dysthymic disorder and. Vasten dosage: 10 Mg/day, Increased To 40 Mg/day On 20-oct-2005. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SERESTA (View Seresta Review and Seresta Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ATHYMIL (View Athymil Review and Athymil Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), TRIATEC (View Triatec Review and Triatec Label ), TEMESTA (View Temesta Review and Temesta Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4890913-9 | Blood Creatinine Increased, Blood Potassium Increased, Blood Urea Increased, Cerebrovascular Accident, Fluid Replacement, Renal Failure Acute
Adverse event was reported on Jan 16, 2006 by a Male patient taking Vasten (View Usage) (Dosage: ) . Location: FRANCE , 78 years of age, weighting 191.8 lb, Patient had the following side effects: blood creatinine increased, blood potassium increased, blood urea increased, cerebrovascular accident, fluid replacement, renal failure acute. During the same period patient was treated with ESOMEPRAZOLE (INEXIUM) (View Esomeprazole (inexium) Review and Esomeprazole (inexium) Label ), COTAREG (View Cotareg Review and Cotareg Label ). Patient was hospitalized.

4879675-9 | Agitation, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Hepatocellular Damage, Hyperbilirubinaemia, Vomiting
on Nov 16, 2005 Female patient from FRANCE , 86 years of age, was treated with Vasten (View Usage). After Vasten was administered, patient had the following side effects: agitation, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, hepatocellular damage, hyperbilirubinaemia, vomiting. Vasten dosage: . During the same period patient was treated with GARDENAL (View Gardenal Review and Gardenal Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), URBANYL (View Urbanyl Review and Urbanyl Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), ARICEPT (View Aricept Review and Aricept Label ), PLATELET AGGREGATION INHIBITOR (View Platelet Aggregation Inhibitor Review and Platelet Aggregation Inhibitor Label ). Patient was hospitalized.

4837250-6 | Agitation, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Hepatitis, Hepatocellular Damage, Hyperbilirubinaemia, Vomiting
on Nov 16, 2005 Female patient from FRANCE , 86 years of age, was treated with Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, hepatitis (What is hepatitis?), hepatocellular damage, hyperbilirubinaemia, vomiting. Vasten dosage: . During the same period patient was treated with GARDENAL (View Gardenal Review and Gardenal Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), URBANYL (View Urbanyl Review and Urbanyl Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), ARICEPT (View Aricept Review and Aricept Label ), PLATELET AGGREGATION INHIBITOR (View Platelet Aggregation Inhibitor Review and Platelet Aggregation Inhibitor Label ). Patient was hospitalized.

4820434-0 | Colitis, Diarrhoea
Patient was taking Vasten (View Usage). Patient had the following side effects: colitis, diarrhoea on Oct 25, 2005 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Vasten dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ARAVA (View Arava Review and Arava Label ), SELOKEN (View Seloken Review and Seloken Label ), MOPRAL (Gastro-resistant Capsules) (View Mopral Review and Mopral Label ), STABLON (View Stablon Review and Stablon Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SEGLOR (View Seglor Review and Seglor Label ). Patient was hospitalized.

4701105-8 | Haematoma, Muscle Rupture, Myalgia
Adverse event was reported on Jun 01, 2005 by a Female patient taking Vasten (View Usage) (Dosage: ) was diagnosed with myocardial infarction, coronary artery disease (What is coronary artery disease?) and. Location: , 51 years of age, After Vasten was administered, patient had the following side effects: haematoma, muscle rupture, myalgia. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

4691734-2 | Tendon Disorder
on Jun 01, 2005 Male patient from , 56 years of age, was treated with Vasten (View Usage). Patient experienced the following unwanted or unexpected effects: tendon disorder. Vasten dosage: . During the same period patient was treated with HYTRINE (View Hytrine Review and Hytrine Label ).

4690687-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Pneumonia Klebsiella, Thrombocythaemia, Urinary Tract Infection Bacterial
on Jun 03, 2005 Female patient from , 73 years of age, was diagnosed with hyperlipidaemia, lung infection, cardiac disorder and was treated with Vasten (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, pneumonia klebsiella, thrombocythaemia, urinary tract infection bacterial. Vasten dosage: . During the same period patient was treated with OFLOCET (View Oflocet Review and Oflocet Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LOVENOX (View Lovenox Review and Lovenox Label ), XANAX (View Xanax Review and Xanax Label ), VASTAREL (View Vastarel Review and Vastarel Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ). Patient was hospitalized.

4688052-5 | Haematoma, Muscle Rupture, Myalgia
Patient was taking Vasten (View Usage). After Vasten was administered, patient had the following side effects: haematoma, muscle rupture, myalgia on Jun 01, 2005 from Additional patient health information: Female patient , 51 years of age, was diagnosed with myocardial infarction and. Vasten dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

4681171-9 | Tendon Rupture
Adverse event was reported on May 11, 2005 by a Male patient taking Vasten (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, myocardial ischaemia, asthma exercise induced and. Location: , 68 years of age, Patient experienced the following unwanted or unexpected effects: tendon rupture. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CELECTOL (View Celectol Review and Celectol Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized and became disabled.

4560569-3 | Pseudo Lymphoma
on Jan 13, 2005 Female patient from , 74 years of age, was diagnosed with hypercholesterolaemia, amaurosis and was treated with Vasten (View Usage). Patient had the following side effects: pseudo lymphoma. Vasten dosage: . During the same period patient was treated with ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ).

4549992-0 | Candidiasis, Exanthem, Rash Pustular
on Jan 05, 2005 Female patient from , 81 years of age, was treated with Vasten (View Usage). After Vasten was administered, patient had the following side effects: candidiasis, exanthem, rash pustular. Vasten dosage: . During the same period patient was treated with MOPRAL (View Mopral Review and Mopral Label ), ZAMUDOL (View Zamudol Review and Zamudol Label ), FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ). Patient was hospitalized.